Private investment in fusion companies has surged from $10 billion to $15 billion in just months, a move that signals a shift in how investors view the technology. The jump reflects a growing belief that fusion could become a real asset class even without an imminent commercial power plant. For decades, fusion has been described as “20 years away,” a timeline that has kept it on the periphery of mainstream funding. Yet the latest funding wave shows that venture capital is treating the field more like biotech or SpaceX, where long horizons are accepted in exchange for high upside. According to the episode, the surge in capital is coming from a mix of traditional VC firms and unexpected sources, underscoring the broad appeal of the technology. The discussion also highlighted the importance of the Q value milestone, a metric that could trigger a public market opening for leading startups. Rebecca Bellan and guest host Tim De Chant noted that fusion has been described as “20 years away” for decades, and they highlighted “fusion euphoria” as a key driver of the recent investment boom. They also mentioned the “Q value milestone” as a potential trigger for a public market debut, while noting that superconducting tape and AI‑assisted plasma physics are quietly doing as much work as the big headline science breakthroughs. The hosts were joined by Rachel Slaybaugh, general partner at DCVC , who emphasized that the return thesis is built on long‑term gains rather than short‑term payoffs. A surprising anecdote from the episode was that a fusion company’s merger with Trump Media and Technology Group prompted Tim to double‑take at his inbox, illustrating the unexpected nature of the capital flow. Looking ahead, the fusion sector appears poised to attract further investment as milestones are approached and technology matures. The episode suggests that investors are willing to accept extended timelines, positioning fusion as a strategic long‑term asset for those looking to diversify beyond conventional energy sources.